BrightFocus Foundation, a nonprofit and premier source of research funding to defeat Alzheimer’s, macular degeneration, and glaucoma, today was acknowledged as the catalyst behind a major advance in drug development for Alzheimer’s disease.
“BrightFocus Foundation lauds today’s historic announcement by Bill Gates of his $50 million investment in the Dementia Discovery Fund. A charitable act of this magnitude is a profound example of the courage and the power of philanthropy to tackle society’s most pressing challenges."
BrightFocus Foundation has announced the awarding of research grants to three scientists at Johns Hopkins University. The grantees’ research topics reflect the three diseases of aging that the foundation is working to end: Alzheimer’s, glaucoma, and macular degeneration.
Alzheimer’s Disease Research (ADR), a BrightFocus Foundation program, is once again proud to participate in employer-sponsored workplace giving campaigns, including the Combined Federal Campaign (CFC), which begins on October 2.